Inventor
VAN LOOKEREN CAMPAGNE MENNO
US18 patents
⚠️ This page may combine multiple inventors who share the name “VAN LOOKEREN CAMPAGNE MENNO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
16 patentsUS8377437B2Feb 19, 2013
C3b antibodies and methods for the prevention and treatment of complement-associated disorders
GENENTECH INC34 citations92
US8007791B2Aug 30, 2011
Prevention and treatment of complement-associated eye conditions
GENENTECH INC26 citations89
US10723795B2Jul 28, 2020
Anti-interleukin-33 antibodies and uses thereof
GENENTECH INC6 citations81
US10093730B2Oct 9, 2018
Anti-interleukin-33 antibodies and uses thereof
GENENTECH INC6 citations81
US11512143B2Nov 29, 2022
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC1 citations71
US10421821B2Sep 24, 2019
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC2 citations71
US10421822B2Sep 24, 2019
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC4 citations71
US9676868B2Jun 13, 2017
Humanized anti-factor D antibodies and uses thereof
GENENTECH INC2 citations71
US11725050B2Aug 15, 2023
Anti-interleukin-33 antibodies and uses thereof
GENENTECH INC1 citations70
US9738727B2Aug 22, 2017
Anti-HtrA1 antibodies and methods of use
GENENTECH INC6 citations68
US10179821B2Jan 15, 2019
Anti-factor D antibodies
GENENTECH INC1 citations60
US10961313B2Mar 30, 2021
Anti-factor D antibody variant conjugates and uses thereof
GENENTECH INC0 citations59
US11760797B2Sep 19, 2023
Anti-interleukin-33 antibodies and uses thereof
GENENTECH INC0 citations55
US10654932B2May 19, 2020
Anti-factor D antibody variant conjugates and uses thereof
GENENTECH INC0 citations49
US10246519B2Apr 2, 2019
NSP4 inhibitors and methods of use
GENENTECH INC0 citations47
US9975963B2May 22, 2018
NSP4 inhibitors and methods of use
GENENTECH INC1 citations47